Cargando…

Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings

Background: Neuroactive steroids (NAS) affect neurotransmitter systems and cognition; thus, they play role in etiopathogenesis of psychiatric disorders. Aims: The primary aim was to examine cognition and effects of NAS on cognitive functioning in first-episode psychosis patients and in their healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Knytl, Pavel, Voráčková, Veronika, Dorazilová, Aneta, Rodriguez, Mabel, Cvrčková, Aneta, Kofroňová, Edita, Kuchař, Martin, Kratochvílová, Zuzana, Šustová, Petra, Čerešňáková, Silvie, Mohr, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591670/
https://www.ncbi.nlm.nih.gov/pubmed/31275177
http://dx.doi.org/10.3389/fpsyt.2019.00390
_version_ 1783429767902527488
author Knytl, Pavel
Voráčková, Veronika
Dorazilová, Aneta
Rodriguez, Mabel
Cvrčková, Aneta
Kofroňová, Edita
Kuchař, Martin
Kratochvílová, Zuzana
Šustová, Petra
Čerešňáková, Silvie
Mohr, Pavel
author_facet Knytl, Pavel
Voráčková, Veronika
Dorazilová, Aneta
Rodriguez, Mabel
Cvrčková, Aneta
Kofroňová, Edita
Kuchař, Martin
Kratochvílová, Zuzana
Šustová, Petra
Čerešňáková, Silvie
Mohr, Pavel
author_sort Knytl, Pavel
collection PubMed
description Background: Neuroactive steroids (NAS) affect neurotransmitter systems and cognition; thus, they play role in etiopathogenesis of psychiatric disorders. Aims: The primary aim was to examine cognition and effects of NAS on cognitive functioning in first-episode psychosis patients and in their healthy siblings. The secondary aims were to verify whether cognitive deficit is an endophenotype of psychosis and whether higher NAS levels represent a high-risk factor for psychosis. Methods: Studied participants were 1) patients with first episode of psychosis, 2) healthy siblings of the patients, and 3) matching healthy controls. Study procedures included administration of a battery of neuropsychological tests assessing six cognitive domains and examination of NAS plasma levels [cortisol (CORT), 11-deoxycorticosterone (DOC), testosterone (TEST), dehydroepiandrostendione (DHEA), dihydrotestosterone (DHT), and progesterone (PROG)]. Results: A total of 67 subjects were analyzed (16 patients, 22 siblings, and 29 controls). Significant group differences were found in most of the cognitive domains; the patients had the lowest scores. The Kruskal–Wallis test revealed significant group differences in CORT levels (p < 0.01), TEST (p < 0.01), and DHT (p < 0.001); no difference was found in PROG, DHEA, and DOC. All cognitive domains, except for attention, were affected by the NAS levels. CORT levels of patients correlated with speed of processing (r = 0.55) and working memory (r = 0.52), while PROG levels correlated with abstraction (r = −0.63). In siblings, there was a negative correlation between TEST levels and verbal memory (r = −0.51) and PROG with attention (r = −0.47). Conclusions: Our results verified that individual domains of cognitive deficit (abstraction and verbal memory) can be considered as an endophenotype of psychosis. Higher levels of cortisol and testosterone in siblings are consistent with high-risk states for psychosis. Multiple interactions between NAS and cognitive functioning, particularly memory functions, were observed. Study limitations (small sample size and administration of antipsychotic medication) did not allow us to establish unequivocally NAS as an endophenotype.
format Online
Article
Text
id pubmed-6591670
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65916702019-07-02 Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings Knytl, Pavel Voráčková, Veronika Dorazilová, Aneta Rodriguez, Mabel Cvrčková, Aneta Kofroňová, Edita Kuchař, Martin Kratochvílová, Zuzana Šustová, Petra Čerešňáková, Silvie Mohr, Pavel Front Psychiatry Psychiatry Background: Neuroactive steroids (NAS) affect neurotransmitter systems and cognition; thus, they play role in etiopathogenesis of psychiatric disorders. Aims: The primary aim was to examine cognition and effects of NAS on cognitive functioning in first-episode psychosis patients and in their healthy siblings. The secondary aims were to verify whether cognitive deficit is an endophenotype of psychosis and whether higher NAS levels represent a high-risk factor for psychosis. Methods: Studied participants were 1) patients with first episode of psychosis, 2) healthy siblings of the patients, and 3) matching healthy controls. Study procedures included administration of a battery of neuropsychological tests assessing six cognitive domains and examination of NAS plasma levels [cortisol (CORT), 11-deoxycorticosterone (DOC), testosterone (TEST), dehydroepiandrostendione (DHEA), dihydrotestosterone (DHT), and progesterone (PROG)]. Results: A total of 67 subjects were analyzed (16 patients, 22 siblings, and 29 controls). Significant group differences were found in most of the cognitive domains; the patients had the lowest scores. The Kruskal–Wallis test revealed significant group differences in CORT levels (p < 0.01), TEST (p < 0.01), and DHT (p < 0.001); no difference was found in PROG, DHEA, and DOC. All cognitive domains, except for attention, were affected by the NAS levels. CORT levels of patients correlated with speed of processing (r = 0.55) and working memory (r = 0.52), while PROG levels correlated with abstraction (r = −0.63). In siblings, there was a negative correlation between TEST levels and verbal memory (r = −0.51) and PROG with attention (r = −0.47). Conclusions: Our results verified that individual domains of cognitive deficit (abstraction and verbal memory) can be considered as an endophenotype of psychosis. Higher levels of cortisol and testosterone in siblings are consistent with high-risk states for psychosis. Multiple interactions between NAS and cognitive functioning, particularly memory functions, were observed. Study limitations (small sample size and administration of antipsychotic medication) did not allow us to establish unequivocally NAS as an endophenotype. Frontiers Media S.A. 2019-06-18 /pmc/articles/PMC6591670/ /pubmed/31275177 http://dx.doi.org/10.3389/fpsyt.2019.00390 Text en Copyright © 2019 Knytl, Voráčková, Dorazilová, Rodriguez, Cvrčková, Kofroňová, Kuchař, Kratochvílová, Šustová, Čerešňáková and Mohr http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Knytl, Pavel
Voráčková, Veronika
Dorazilová, Aneta
Rodriguez, Mabel
Cvrčková, Aneta
Kofroňová, Edita
Kuchař, Martin
Kratochvílová, Zuzana
Šustová, Petra
Čerešňáková, Silvie
Mohr, Pavel
Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title_full Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title_fullStr Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title_full_unstemmed Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title_short Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
title_sort neuroactive steroids and cognitive functions in first-episode psychosis patients and their healthy siblings
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591670/
https://www.ncbi.nlm.nih.gov/pubmed/31275177
http://dx.doi.org/10.3389/fpsyt.2019.00390
work_keys_str_mv AT knytlpavel neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT vorackovaveronika neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT dorazilovaaneta neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT rodriguezmabel neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT cvrckovaaneta neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT kofronovaedita neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT kucharmartin neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT kratochvilovazuzana neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT sustovapetra neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT ceresnakovasilvie neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings
AT mohrpavel neuroactivesteroidsandcognitivefunctionsinfirstepisodepsychosispatientsandtheirhealthysiblings